Erythema annulare centrifugum as presenting sign of activation of breast cancer

Abstract

Erythema annulare centrifugum is a figurate erythema of unknown etiology. It has been associated with many different entities, including infections, food allergy, drug reactions and malignant neoplasms. Herein, we report a case of erythema annulare centrifugum as presenting sign of activation of breastcancer.

Evaluation of Clinicopathological Features and Associated Conditions in Erythema Annulare Centrifugum: A Retrospective Observational Analysis of 63 Patients

“…In the study by Weyers et al the number of patients with associated malignancy was 6 (13.33% of those with an associated disease) and the disease was active in only one of these patients [ 4 ]. In a patient diagnosed with breast cancer EAC was associated with disease activation and lymph node metastasis was found [ 9 ]. In that case, it was emphasized that if EAC occurred due to an underlying disease, EAC may be correlated with exacerbations of this disease [ 9 ].…”

“…In a patient diagnosed with breast cancer EAC was associated with disease activation and lymph node metastasis was found [ 9 ]. In that case, it was emphasized that if EAC occurred due to an underlying disease, EAC may be correlated with exacerbations of this disease [ 9 ]. The possible activation of cancer was also investigated in our patients who were in remission but no recurrence of malignancy was detected.…”

“…Paraneoplastic EAC associated with malignancy is called PEACE (paraneoplastic erythema annulare centrifugum eruption) [ 8 ]. EAC may start years before, simultaneously or later than malignancy [ 9 ]. The first approach in the treatment of EAC is to treat the underlying disease if one is detected.…”

Eritema anular centrífugo como marcador cutáneo de comorbilidades

“…11 Dentro de los reportes de casos en la literatura, encontramos dos con linfoma no Hodgkin, uno con linfoma de Hodgkin, uno con leucemia linfocítica aguda, uno con leucemia aguda promielocítica, tres casos de leucemia linfocítica crónica, uno con leucemia mieloide crónica, uno con histiocitosis maligna, uno con adenocarcinoma papilar seroso de ovario, dos con neoplasia pulmonar, uno con carcinoma de mama y cuatro con carcinoma recurrente o metastásico. [11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29] Otros padecimientos asociados son las infecciones. En la literatura consultada, encontramos un mayor núwww.medigraphic.com/dermatologicopascua www.medigraphic.org.mx cuadro dermatológico tras haber recibido manejo para la comorbilidad subyacente, con un promedio de 11 semanas entre el manejo y la resolución de la dermatosis.…”